How to classify polyneuropathy by electrodiagnostic?
Keywords:
polyneuropathy, demyelinating, axonal, mixed, electrodiagnostic criteria, classification.Abstract
Objectives: to evaluate the existing electrodiagnostic criteria for classifying a polyneuropathy as axonal, demyelinating or mixed.Methods: were consulted Medline, CINAHL, Scielo and Embasse databases and Dimitru, Oh, Kimura, Preston and Tan textbooks.
Results: for demyelinating polyneurophaties eighteen criteria were found, four for axonal and two for mixed. To be supported by scientific societies were chosen, for demyelinating polyneurophaties, the criteria proposed by the American Academy of Neurology (AAN) and the European Federation of Neurological Societies/ Peripheral Nerve Society (EFSN/PNS). For mixed and axonal polineurophaties the criteria proposed for diferents autors were described.
Conclusions: the electrodiagnosis is fundamental to the study, evolution and prognosis of polyneuropathy.
References
1. AAEM. Guidelines in electrodiagnostic medicine. Muscle Nerve 1992; 15(2):249.
2. Albers JW, Kelly JJ Jr. Acquired demyelinating polyneuropathies: clinical and elec- trodiagnostic features. Muscle Nerve1989;12:435-51.
3. Amato A, Dimitru D. Aproach to peripheral neurophaty. In: Dumitru D, Amato AA, Zwarts M( eds). Electrodiagnostic Medicine. 2 ed. Philadelphia: Hanley & Belfus; 2002: 890
4. American Association of Electrodiagnostic Medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999;22:S225-S229
5. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic Inflammatory Demyelinating Polyradiculoneuropathy: clinical characteristics, course, and recommendations for Diagnostic Criteria. Arch Neurol 1989;46: 878-84.
6. Bragg JA, Benatar MG. Sensory nerve conduction slowing is a specific marker for CIDP. Muscle Nerve 2008;38:1599-1603.
7. Bril V, Banach M, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Katzberg H, Latov N, Merkies IS, Van Doorn PA; ICE Study Group. Electrophysiologic correlations with clinical outcomes in CIDP. Muscle Nerve. 2010 Oct;42(4):492-7.
8. Bromberg MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy.Muscle Nerve. 1991;14:968-76.
9. Bromberg MB. Muscle Nerve. Review of the evolution of electrodiagnóstic criteria for chronic inflamatory demyelinating polyradicoloneurophaty. Muscle Nerve 2011;43: 780-94.
10. Bromberg M, Albers J. Patterns of sensory nerve conduction abnormalities in demyelina ting and axonal peripheral nerve disorders. Muscle Nerve 1993;16:262-66.
11. Buschbacher R, Pralow N. Manual of nerve conduction studies. 2ed. New York: Demos Medical Publishing; 2006: 299 páginas.
12. Campbell WW, Robinson LR: Deriving reference values in electrodiagnostic medicine. Muscle Nerve 1993;16:424-28.
13. Checkles NS, Russakov AD, Piero DL. Ulnar nerve conduction velocity: Effect of elbow position on measurement. Arch Phys Med Rehabil 1971;52:32-62.
14. Dimitru D, Amato A, Zwarts M. Nerve conduction studies. In: Dumitru D, Amato AA, Zwarts M (eds). Electrodiagnostic Medicine. 2 ed. Philadelphia: Hanley & Belfus; 2002:159-224.
15. De Sousa EA, Chin RL, Sander HW, Latov N, Brannagan TH III.Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity. J Clin Neuromuscul Dis 2009;10:163-69.
16. Donofrio P, Albers J. AAEM minimonography #34: Polyneurophaty: classification by nerve conduction studies and electromyography. Muscle Nerve 1990; 13(10): 889- 903.
17. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies andthe Peripheral Nerve Society - First Revision. J Peripher Nerv Syst 2010; 15(1):1-9.
18. Fu R, DeLisa JA, Kraft GH. Motor nerve latencies through the tarsal tunnel in normal adult subjects: standard determinations corrected for temperature and distance. Arch Phys Med Rehabil 1980;61:243-48.
19. Goodmann BP,Harper CM, Boon AJ. Prolonged compound muscle action potential duration in critical illness myopathy. Muscle Nerve 2009; 40: 1040-42.
20. Gutmann L, Pawar G. An Approach to Electrodiagnosis of Peripheral Neuropathies. Sem neurol 2005; 25(2): 160-67.
21. Hadden RDM, Hughes RAC, Cornblath DR, Zielasek J, Hartung H-P, Toyka KV, Swann AV. Electrophysiological classification of Guillain-Barre´ syndrome: Clinical associations and outcome. Ann Neurol 1998;44:780-88.
22. Haq RU, Fries TJ, Pendlebury WW, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol. 2000;57:1745-50.
23. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW,Asbury AK, Blaser MJ, McKhann GM. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni in infection and antiglycolipid antibodies. Brain 1995;118: 597-605.
24. Hughes R, Bensa S, Willison H, et al. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50: 195-201.
25. Isose S, Kuwabara S, Kokubun N, Sato Y, Mori M, Shibuya K,Sekiguchi Y, Nasu S, Fujimaki Y, Noto Y, Sawai S, Kanai K, Hirata K,Misawa S. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peri pher Nerv Syst 2009; 14: 151-58.
26. Jimenez J, Easton JKM, Redford JB. Conduction studies of the anterior and posterior tibial nerves. Arch Phys Med Rehabil 1970;51:164-69.
27. Kelly J. The electrodiagnostic findings in peripheral neuropathy associated with monoclo nal gammopathy. Muscle Nerve 1983;6:504-09.
28. Kimura J: Assessment of individual nerves. In: Kimura J (ed). Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 3 ed. Philadelphia, FA Davis; 1993: 103-38.
29. Koski CL, Baumgarten M,Magder LS, et al. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy.J Neurol Sci 2009;277:1-8.
30. Lee HJ, DeLisa JA. Manual of nerve conduction study and surface anatomy for needle electromyography. 4 ed. Philadelphia: Lippincott Williams & Wilkins; 2005: 235 pages.
31. Magda P, Latov N, Brannagan TH, Chin RL, Sander HW. Minimal electrodiagnostic criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 2003;60:A489.
32. Melvin JL, Harris DH, Johnson EW: Sensory and motor conduction velocities in the ulnar and median nerves. Arch Phys Med Rehabil 1966;47:511-19.
33. Meulstee J, van der Meche´ F, and the Dutch Guillain-Barré Study Group: Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barre´ syndrome. J Neurol Neurosurg Psychiatry 1995;59: 482-86
34. Murray N, Wade D. The sural sensory action potential in Guillain-Barré syndrome. Muscle Nerve 1980;3:444.
35. Nicolas G, Maisonobe T, Le Forestier N, et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25:26-30.
36. Oh SJ. Normal values for common nerve conduction test. In: Oh SJ (ed). Clinical Electromygraphy. 3 ed. Philadelphia: Lippincott Williams & Wilkins; 2003: 86-106.
37. Oh SJ. Required tests for specific problems. In: Oh SJ (ed). Clinical Electromygraphy. 3 ed. Philadelphia: Lippincott Williams & Wilkins; 2003: 79.
38. Ortiz-Corredor F, López-Monsalve A. Aproximación a valores de referencia de estudios electrofisiológicos para el diagnóstico del síndrome del túnel del carpo. Rev. Salud Pública 2009; 11(5): 794-801.
39. Park EJ, Nishida T, Sufit RL, Minieka MM. Prolonged compound muscle action potential duration in critical illness myopathy: report of nine cases. J Clin Neuromusc Dis 2004;5:176-83.
40. Preston DC, Shapiro BE . Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic Correlations. 2 ed. Boston: Butterworth-Heinemann; 1997: 355-90
41. Rajabally YA, Jacob S. Proximal nerve conduction studies in chronic inflammatory de- myelinating polyneuropathy. Clin Neurophysiol 2006;117:2079-84.
42. Rajabally YA, Narasimhan M. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2007;118:1999-2004.
43. Rajabally YA, Nicolas G, Pieret F, Bouche P, Van den Bergh PY. Validity of diagnostic crite ria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009;80:1364-68.
44. Robinson LR, Temkin NR, Fujimoto WY, Stolov WC: Effect of statistical methodology on normal limits in nerve conduction studies. Muscle Nerve 1991;14:1084-90.
45. Ross MA. Polyneurophaty. In: Tan FC (ed).Emg Secrets. 1st ed. Philadelphia: Hanley & Belfus; 2002:178.
46. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003;60(8 Suppl 3):S8-15.
47. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24(3):311-24.
48. Simmons Z, Wald JJ, Albers JW. Chronic inflammatory demyelinating polyradiculoneu -ropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve. 1997 Dec;20(12):1569-75.
49. Simmons Z, Wald JJ, Albers JW. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults. Muscle Nerve. 1997 Aug;20(8):1008-15.
50. Tankisi H, Pugdahl K, Fuglsang-Frederiksen A, Johnsen B, de CarvalhoM, Fawcett PR, et al. Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines. Clin Neurophysiol 2005;116: 1571-80.
51. Thaisetthawatkul P, Logigian E, Herrmann D. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology2002;59:1526-32.
52. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barre syndrome. A multicentre prospective study of 297 patients. Brain 1996;119:2053 61.
53. Van den Bergh PYK, Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004; 29: 565-74.
2. Albers JW, Kelly JJ Jr. Acquired demyelinating polyneuropathies: clinical and elec- trodiagnostic features. Muscle Nerve1989;12:435-51.
3. Amato A, Dimitru D. Aproach to peripheral neurophaty. In: Dumitru D, Amato AA, Zwarts M( eds). Electrodiagnostic Medicine. 2 ed. Philadelphia: Hanley & Belfus; 2002: 890
4. American Association of Electrodiagnostic Medicine. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999;22:S225-S229
5. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic Inflammatory Demyelinating Polyradiculoneuropathy: clinical characteristics, course, and recommendations for Diagnostic Criteria. Arch Neurol 1989;46: 878-84.
6. Bragg JA, Benatar MG. Sensory nerve conduction slowing is a specific marker for CIDP. Muscle Nerve 2008;38:1599-1603.
7. Bril V, Banach M, Dalakas MC, Deng C, Donofrio P, Hanna K, Hartung HP, Hughes RA, Katzberg H, Latov N, Merkies IS, Van Doorn PA; ICE Study Group. Electrophysiologic correlations with clinical outcomes in CIDP. Muscle Nerve. 2010 Oct;42(4):492-7.
8. Bromberg MB. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy.Muscle Nerve. 1991;14:968-76.
9. Bromberg MB. Muscle Nerve. Review of the evolution of electrodiagnóstic criteria for chronic inflamatory demyelinating polyradicoloneurophaty. Muscle Nerve 2011;43: 780-94.
10. Bromberg M, Albers J. Patterns of sensory nerve conduction abnormalities in demyelina ting and axonal peripheral nerve disorders. Muscle Nerve 1993;16:262-66.
11. Buschbacher R, Pralow N. Manual of nerve conduction studies. 2ed. New York: Demos Medical Publishing; 2006: 299 páginas.
12. Campbell WW, Robinson LR: Deriving reference values in electrodiagnostic medicine. Muscle Nerve 1993;16:424-28.
13. Checkles NS, Russakov AD, Piero DL. Ulnar nerve conduction velocity: Effect of elbow position on measurement. Arch Phys Med Rehabil 1971;52:32-62.
14. Dimitru D, Amato A, Zwarts M. Nerve conduction studies. In: Dumitru D, Amato AA, Zwarts M (eds). Electrodiagnostic Medicine. 2 ed. Philadelphia: Hanley & Belfus; 2002:159-224.
15. De Sousa EA, Chin RL, Sander HW, Latov N, Brannagan TH III.Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity. J Clin Neuromuscul Dis 2009;10:163-69.
16. Donofrio P, Albers J. AAEM minimonography #34: Polyneurophaty: classification by nerve conduction studies and electromyography. Muscle Nerve 1990; 13(10): 889- 903.
17. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies andthe Peripheral Nerve Society - First Revision. J Peripher Nerv Syst 2010; 15(1):1-9.
18. Fu R, DeLisa JA, Kraft GH. Motor nerve latencies through the tarsal tunnel in normal adult subjects: standard determinations corrected for temperature and distance. Arch Phys Med Rehabil 1980;61:243-48.
19. Goodmann BP,Harper CM, Boon AJ. Prolonged compound muscle action potential duration in critical illness myopathy. Muscle Nerve 2009; 40: 1040-42.
20. Gutmann L, Pawar G. An Approach to Electrodiagnosis of Peripheral Neuropathies. Sem neurol 2005; 25(2): 160-67.
21. Hadden RDM, Hughes RAC, Cornblath DR, Zielasek J, Hartung H-P, Toyka KV, Swann AV. Electrophysiological classification of Guillain-Barre´ syndrome: Clinical associations and outcome. Ann Neurol 1998;44:780-88.
22. Haq RU, Fries TJ, Pendlebury WW, et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol. 2000;57:1745-50.
23. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW,Asbury AK, Blaser MJ, McKhann GM. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni in infection and antiglycolipid antibodies. Brain 1995;118: 597-605.
24. Hughes R, Bensa S, Willison H, et al. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50: 195-201.
25. Isose S, Kuwabara S, Kokubun N, Sato Y, Mori M, Shibuya K,Sekiguchi Y, Nasu S, Fujimaki Y, Noto Y, Sawai S, Kanai K, Hirata K,Misawa S. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peri pher Nerv Syst 2009; 14: 151-58.
26. Jimenez J, Easton JKM, Redford JB. Conduction studies of the anterior and posterior tibial nerves. Arch Phys Med Rehabil 1970;51:164-69.
27. Kelly J. The electrodiagnostic findings in peripheral neuropathy associated with monoclo nal gammopathy. Muscle Nerve 1983;6:504-09.
28. Kimura J: Assessment of individual nerves. In: Kimura J (ed). Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. 3 ed. Philadelphia, FA Davis; 1993: 103-38.
29. Koski CL, Baumgarten M,Magder LS, et al. Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy.J Neurol Sci 2009;277:1-8.
30. Lee HJ, DeLisa JA. Manual of nerve conduction study and surface anatomy for needle electromyography. 4 ed. Philadelphia: Lippincott Williams & Wilkins; 2005: 235 pages.
31. Magda P, Latov N, Brannagan TH, Chin RL, Sander HW. Minimal electrodiagnostic criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 2003;60:A489.
32. Melvin JL, Harris DH, Johnson EW: Sensory and motor conduction velocities in the ulnar and median nerves. Arch Phys Med Rehabil 1966;47:511-19.
33. Meulstee J, van der Meche´ F, and the Dutch Guillain-Barré Study Group: Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barre´ syndrome. J Neurol Neurosurg Psychiatry 1995;59: 482-86
34. Murray N, Wade D. The sural sensory action potential in Guillain-Barré syndrome. Muscle Nerve 1980;3:444.
35. Nicolas G, Maisonobe T, Le Forestier N, et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25:26-30.
36. Oh SJ. Normal values for common nerve conduction test. In: Oh SJ (ed). Clinical Electromygraphy. 3 ed. Philadelphia: Lippincott Williams & Wilkins; 2003: 86-106.
37. Oh SJ. Required tests for specific problems. In: Oh SJ (ed). Clinical Electromygraphy. 3 ed. Philadelphia: Lippincott Williams & Wilkins; 2003: 79.
38. Ortiz-Corredor F, López-Monsalve A. Aproximación a valores de referencia de estudios electrofisiológicos para el diagnóstico del síndrome del túnel del carpo. Rev. Salud Pública 2009; 11(5): 794-801.
39. Park EJ, Nishida T, Sufit RL, Minieka MM. Prolonged compound muscle action potential duration in critical illness myopathy: report of nine cases. J Clin Neuromusc Dis 2004;5:176-83.
40. Preston DC, Shapiro BE . Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic Correlations. 2 ed. Boston: Butterworth-Heinemann; 1997: 355-90
41. Rajabally YA, Jacob S. Proximal nerve conduction studies in chronic inflammatory de- myelinating polyneuropathy. Clin Neurophysiol 2006;117:2079-84.
42. Rajabally YA, Narasimhan M. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol 2007;118:1999-2004.
43. Rajabally YA, Nicolas G, Pieret F, Bouche P, Van den Bergh PY. Validity of diagnostic crite ria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009;80:1364-68.
44. Robinson LR, Temkin NR, Fujimoto WY, Stolov WC: Effect of statistical methodology on normal limits in nerve conduction studies. Muscle Nerve 1991;14:1084-90.
45. Ross MA. Polyneurophaty. In: Tan FC (ed).Emg Secrets. 1st ed. Philadelphia: Hanley & Belfus; 2002:178.
46. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology 2003;60(8 Suppl 3):S8-15.
47. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24(3):311-24.
48. Simmons Z, Wald JJ, Albers JW. Chronic inflammatory demyelinating polyradiculoneu -ropathy in children: I. Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve. 1997 Dec;20(12):1569-75.
49. Simmons Z, Wald JJ, Albers JW. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults. Muscle Nerve. 1997 Aug;20(8):1008-15.
50. Tankisi H, Pugdahl K, Fuglsang-Frederiksen A, Johnsen B, de CarvalhoM, Fawcett PR, et al. Pathophysiology inferred from electrodiagnostic nerve tests and classification of polyneuropathies. Suggested guidelines. Clin Neurophysiol 2005;116: 1571-80.
51. Thaisetthawatkul P, Logigian E, Herrmann D. Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathy. Neurology2002;59:1526-32.
52. The Italian Guillain-Barré Study Group. The prognosis and main prognostic indicators of Guillain-Barre syndrome. A multicentre prospective study of 297 patients. Brain 1996;119:2053 61.
53. Van den Bergh PYK, Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004; 29: 565-74.
How to Cite
1.
Hoyos Arango B. How to classify polyneuropathy by electrodiagnostic?. Rev. Colomb. Med. Fis. Rehabil. [Internet]. 2012 Apr. 14 [cited 2024 May 12];21(2):101-12. Available from: https://revistacmfr.org/index.php/rcmfr/article/view/13
Downloads
Download data is not yet available.
